Results 101 to 110 of about 21,846 (223)

Abscopal Effect in Radiation Therapy: The Immune Mechanisms and Clinical Advances

MedComm, Volume 7, Issue 9, September 2026.
The schematic outlines the key events of the abscopal effect. (Ignition) Local radiotherapy (RT) induces the release of immunogenic signals from the tumor, leading to dendritic cell (DC) activation. (Orchestration) In the tumor‐draining lymph node (TDLN), DCs prime naive T cells into cytotoxic T lymphocytes (CTLs), a process modulated by regulatory T ...
Yihong Dong, Moran Chen, Xupeng Hou, Xiaoya Tang, Xiaoli Yu, Jing Liu   +5 more
wiley   +1 more source

Therapeutic Management of a Case of Severe Psoriasis Coexistent with Bullous Pemphigoid in the Elderly

Psoriasis: Targets and Therapy, 2023
Vito Di Lernia, Francesca Peccerillo, Elena Ficarelli Dermatology Unit, Azienda Unità Sanitaria Locale- IRCCS di Reggio Emilia, Reggio Emilia, ItalyCorrespondence: Vito Di Lernia, Dermatology Unit, Arcispedale Santa Maria Nuova, Azienda USL-IRCCS di ...
Di Lernia V, Peccerillo F, Ficarelli E
doaj  

Bullous Pemphigoid [PDF]

JAMA Dermatology, 2013
Misha, Rosenbach, Karolyn A, Wanat, Cassio, Lynm   +2 more
openaire   +2 more sources

Dupilumab as a treatment for bullous pemphigoid in a liver transplant recipient: A case report

SAGE Open Medical Case Reports
Bullous pemphigoid is a common subepidermal autoimmune bullous disease that affects the skin and mucous membranes. It is more prevalent in the elderly, often resulting in significant morbidity and mortality.
Sarah S. Rashid, P. Régine Mydlarski, Fatemeh Jafarian   +2 more
doaj   +1 more source

Bullous Pemphigoid [PDF]

Journal of General Internal Medicine, 2012
Barry, Ladizinski, Kachiu Cecelia, Lee
openaire   +2 more sources

The association between COVID‐19 vaccines and bullous pemphigoid risk: A UK population‐based study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Mikolaj Swiderski, Yana Vinogradova, Matthew J. Ridd, Zenas Z. N. Yiu, Antonia Lloyd‐Lavery, Vibhore Prasad, Bruno Gran, Sonia Gran   +7 more
wiley   +1 more source

Type‐2‐Inflammatory‐Diseases Share Comorbidities, Molecular Signatures, IL4/IL13 Genetics, and Response to IL4/IL13 Blockade

Allergy, Volume 81, Issue 9, Page 3345-3360, September 2026.
Studies suggest that type 2 inflammatory diseases are driven by overactivation of the IL4/IL13 pathway, manifesting differently in distinct tissues. We performed quantitative analyses using several large independent datasets to explore the interrelation of type 2 inflammatory diseases based on co‐prevalence, genetic predispositions, and transcriptomic ...
Jennifer D. Hamilton, Manuel A. R. Ferreira, Wei Keat Lim, Carlo Sidore, Matthew F. Wipperman, Wenzhen Ge, Xue Song, Changming Xia, Julie E. Horowitz, Andrea T. Hooper, Sara C. Hamon, Jennifer Maloney, Jamie M. Orengo, Zhen Chen, Stephanie Amato Ricci, Bolanle Akinlade, Aris Baras, Gary Herman, Brandy L. Bennett, George D. Yancopoulos   +19 more
wiley   +1 more source

Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients

Frontiers in Immunology, 2018
Background: Bullous pemphigoid is a subepidermal blistering skin disease, associated with autoantibodies to hemidesmosomal proteins, complement activation at the dermal-epidermal junction, and dermal granulocyte infiltration.
Roxana M. Chiorean, Roxana M. Chiorean, Adrian Baican, Mayson B. Mustafa, Annette Lischka, Daniel-Corneliu Leucuta, Vasile Feldrihan, Michael Hertl, Cassian Sitaru, Cassian Sitaru   +9 more
doaj   +1 more source

Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor in primary care: Case report

Turkish Journal of Family Practice
Bullous pemphigoid is the most common bullous chronic autoimmune skin disease. Recent studies suggest dipeptidyl peptidase-4 inhibitors used in the treatment of type-2 diabetes as possible predisposing agents of bullous pemphigoid.
Kübra Kurt
doaj   +1 more source

Supplementary data for "Immune Checkpoint Inhibitor-Associated Bullous Pemphigoid: A Distinct Disease Beyond Classic Bullous Pemphigoid"

Supplementary data for "Immune Checkpoint Inhibitor-Associated Bullous Pemphigoid: A Distinct Disease Beyond Classic Bullous Pemphigoid", including 2 supplementary ...
Chen, Linqiao
core   +1 more source